Mycophenolate Mofetil Powder, For Suspension
Product Images NDC 60219-1595

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Mycophenolate Mofetil (NDC 60219-1595). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3 (Mycophenolate Mofetil Oral Suspension 1)

3 (Mycophenolate Mofetil Oral Suspension 1)
Chemical structure of Mycophenolate Mofetil, illustrating its molecular configuration with rings, functional groups including ester and ether linkages, and oxygen and nitrogen atoms as part of the molecule.*
FDA Label Image

1 (Mycophenolate Mofetil Oral Suspension 2)

1 (Mycophenolate Mofetil Oral Suspension 2)
An instructional diagram for Mycophenolate Mofetil oral suspension packaging from Amneal Pharmaceuticals. It shows a child-resistant bottle cap, a bottle adapter, and a bottle. Below, the oral dispenser syringe is detailed with labeled parts: plunger and barrel, including dosage markings on the barrel.*
FDA Label Image

2 (Mycophenolate Mofetil Oral Suspension 3)

2 (Mycophenolate Mofetil Oral Suspension 3)
An instructional illustration showing the preparation of a suspension dose. One hand holds an inverted bottle of Mycophenolate Mofetil powder for suspension, while the other hand holds a syringe or dosing device positioned to draw the liquid from the bottle. The figure is labeled as Figure 2.*
FDA Label Image

1 (Mycophenolate Mofetil Oral Suspension 4)

1 (Mycophenolate Mofetil Oral Suspension 4)
Mycophenolate Mofetil for Oral Suspension, USP 200 mg/mL powder for suspension label by Amneal Pharmaceuticals NY LLC. The label indicates each mL contains 200 mg mycophenolate mofetil USP. It includes usage directions, storage conditions, manufacturer details (Amneal Pharmaceuticals Pvt. Ltd., India), and a barcode. It instructs dispensing the accompanying Medication Guide to patients.*
FDA Label Image

2 (Mycophenolate Mofetil Oral Suspension 5)

2 (Mycophenolate Mofetil Oral Suspension 5)
Packaging label for Mycophenolate Mofetil Oral Suspension, USP 200 mg/mL powder for suspension by Amneal Pharmaceuticals NY LLC. The label details net contents, deliverable volume, phenylketonurics warning, storage instructions, and pharmacist directions. Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.